ArticleBlood neoplasia2026

Epigenetic activation of EBV BGLF4 determines antiviral-based regimen response in EBV+CNS lymphoproliferative disease.

Christoph Weigel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.